Numerical scoring for the Classic BILAG index

Rheumatology

Volumn 48, Issue 12, 2009, Pages 1548-1552

  Cresswell, Lynne ^a   Yee, Chee Seng ^b   Farewell, Vernon ^a   Rahman, Anisur ^c   Teh, Lee Suan ^d   Griffiths, Bridget ^e   Bruce, Ian N ^f   Ahmad, Yasmeen ^g   Prabu, Athiveeraramapandian ^b   Akil, Mohammed ^h   McHugh, Neil ⁱ   Toescu, Veronica ^b   D'Cruz, David ^j   Khamashta, Munther A ^j   Maddison, Peter ^k   Isenberg, David A ^c   Gordon, Caroline ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ROYAL BLACKBURN HOSPITAL   (United Kingdom)

^e FREEMAN HOSPITAL   (United Kingdom)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

^g North West Wales NHS Trust ^*  (United Kingdom)

^h SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

ⁱ ROYAL UNITED HOSPITALS BATH NHS FOUNDATION TRUST   (United Kingdom)

^j ST THOMAS HOSPITAL   (United Kingdom)

^k BANGOR UNIVERSITY   (United Kingdom)

more..

Author keywords

BILAG; Disease activity; Global score; Outcome measures; Regression model; SLE; Statistics; Treatment decision

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; ARTICLE; CLASSIC BILAG INDEX; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT PLANNING; VALIDATION STUDY;

ADULT; ANTIRHEUMATIC AGENTS; DRUG ADMINISTRATION SCHEDULE; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 75649133126     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep183     Document Type: Article

References (13)

1. Hay EM, Bacon PA, Gordon C et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 1993;86:447-58.
2. Brunner HI, Feldman BM, Bombardier C, Silverman ED. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum 1999;42:1354-60.
3. Ward MM, Marx AS, Barry NN. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus. J Rheumatol 2000;27:664-70.
4. Stoll T, Stucki G, Malik J, Pyke S, Isenberg DA. Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus. J Rheumatol 1997;24:309-13.
5. Yee CS, Farewell V, Isenberg DA et al. British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 2007;56:4113-19.
6. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
7. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
8. Isenberg DA, Gordon C. From BILAG to BLIPS-disease activity assessment in lupus past, present and future. Lupus 2000;9:651-4.
9. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-77.
10. Guzman J, Cardiel MH, rce-Salinas A, Sanchez-Guerrero J, Alarcon-Segovia D. Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol 1992;19:1551-8.
11. Gladman DD, Goldsmith CH, Urowitz MB et al. Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. J Rheumatol 1992;19:608-11.
12. Gladman DD, Goldsmith CH, Urowitz MB et al. Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation. J Rheumatol 1994;21:1468-71.
13. Wollaston SJ, Farewell VT, Isenberg DA et al. Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics group. J Rheumatol 2004;31:2390-4.